What is the typical dosing for CJC-1295 DAC?

Doses from research protocols. Common doses observed in research: 1-2 mg weekly, Some use twice weekly. Duration: 8-12 weeks typical. Administration: Subcutaneous injection.

Growth Hormone

CJC-1295 DAC

Also known as: Modified GRF 1-29 DAC, Drug Affinity Complex CJC

Clinical Trials

Buy in shop

CJC-1295 DAC from $86/kit

3 verified vendors, ≥99% purity, COAs included.

Compare prices

Key Facts: CJC-1295 DAC

Category: Growth Hormone
FDA Status: Not FDA Approved
Clinical Status: Investigational - Research compound
Administration: Subcutaneous injection
Typical Dose: Limited community data available
Frequency: See research protocols
Duration: 8-12 weeks typical

Also Known As

Modified GRF 1-29 DAC, Drug Affinity Complex CJC

Mechanism of Action

CJC-1295 DAC contains a reactive linker that binds to albumin after injection. This extends half-life from minutes to 6-8 days, providing sustained GHRH stimulation and GH/IGF-1 elevation.

Research Summary

Studies show sustained 2-10 fold increase in GH levels lasting several days. Single weekly injection maintains elevated IGF-1. Less physiologic than pulsatile protocols but more convenient.

Trial Progress:Preclinical

Pre

III

FDA

Dosing Information

Human Trials·Human studies conducted, not FDA approved

Typical DosingⓘDoses commonly used by people in practice, based on community reports and anecdotal experience.

Community experience

Common Dose

Limited community data available

Range

See research dosing

Frequency

See research protocols

Research DosingⓘDoses from published scientific studies and clinical trials. May include human or animal research.

Scientific studies

Doses from research protocols

Doses from Studies

1-2 mg weekly

Research Literature - Observed in studies ↗

Some use twice weekly

Research Literature - Observed in studies ↗

Duration

8-12 weeks typical

Administration

Subcutaneous injection

Timing & Administration

Best Time to Take

Before bed or morning (fasted)

Follow specific peptide protocol

Food Recommendation

Take on empty stomach

Why This Timing?

GH-related peptides work best on an empty stomach to maximize growth hormone release.

Possible Side Effects

Not everyone experiences these effects. Individual responses vary based on dosage, duration, and personal factors.

●Generally well-tolerated
●Injection site reactions
●Facial flushing
●Water retention
●Headache
●Side effects persist longer due to 8-day half-life
●May trigger histamine release - use caution with MCAS or histamine sensitivity
●Clinical trial discontinued

References

Research This Peptide Further

PubMed ClinicalTrials.gov FDA.gov

Buy in shop

CJC-1295 DAC from $86/kit

3 verified vendors, ≥99% purity, COAs included.

Compare prices

Frequently Asked Questions

What does CJC-1295 DAC do?

A long-acting GHRH analog with Drug Affinity Complex for extended half-life. Provides sustained GH elevation for days with single injection.

How does CJC-1295 DAC work?

CJC-1295 DAC contains a reactive linker that binds to albumin after injection. This extends half-life from minutes to 6-8 days, providing sustained GHRH stimulation and GH/IGF-1 elevation.

Is CJC-1295 DAC FDA approved?

No, CJC-1295 DAC is not currently FDA approved. Current status: Investigational - Research compound

What are the side effects of CJC-1295 DAC?

Reported side effects include: Generally well-tolerated, Injection site reactions, Facial flushing, Water retention, Headache. Individual responses vary based on dosage, duration, and personal health factors.

What is the typical dose of CJC-1295 DAC?

Community-reported common dose: Limited community data available (See research protocols). Range: See research dosing. Administration: Subcutaneous injection. Community-reported doses. Not medical advice. Consult healthcare provider.

Related Peptides

Peptides commonly compared with CJC-1295 DAC or used in similar applications.

Ipamorelin

Clinical Trials

A selective growth hormone secretagogue that stimulates GH release without significantly affecting cortisol or prolactin. Considered one of the safest GHRPs.

Growth Hormone

MK-677

Clinical Trials

An orally active growth hormone secretagogue that mimics ghrelin. Although technically not a peptide, it is frequently discussed alongside GH peptides due to similar effects.

Growth Hormone

CJC-1295 (No DAC)

Clinical Trials

A synthetic analog of growth hormone-releasing hormone (GHRH) that stimulates GH release from the pituitary. Often combined with a GHRP like Ipamorelin for synergistic effects.

Growth Hormone

Tesamorelin

FDA

An FDA-approved GHRH analog used to reduce excess abdominal fat in HIV-infected patients with lipodystrophy. New F8 formulation (Egrifta WR) approved March 2025 allows weekly reconstitution vs daily.

Growth Hormone

GHRP-6

Clinical Trials

One of the first synthetic GH secretagogues developed. Strongly stimulates GH release and significantly increases appetite through ghrelin receptor activation.

Growth Hormone

GHRP-2

Clinical Trials

A synthetic hexapeptide that potently stimulates GH release. More potent than GHRP-6 with less appetite stimulation, but still elevates cortisol and prolactin.

Growth Hormone

How to Use CJC-1295 DAC CJC-1295 DAC Alternatives Compare with Similar Browse All Peptides

Want updates on CJC-1295 DAC research?

Subscribe to get notified when we add new research findings, protocol updates, and related peptide information.

Back to all peptides